Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 Research Tendon Considerations: Study Comparison

Rat Achilles Transection (2016) Intraperitoneal 10 mcg/kg daily Tensile strength at 14 days 47% increase vs control Strong model for acute injury; IP route provides systemic effect but lower local concentration Rat Patellar Tendon Defect (2018) Intramuscular (

This comparison does not assign a generated winner or score.

  • Rat Achilles Transection (2016)
  • Intraperitoneal
  • 10 mcg/kg daily
  • Tensile strength at 14 days
  • 47% increase vs control
  • Strong model for acute injury; IP route provides systemic effect but lower local concentration
  • Rat Patellar Tendon Defect (2018)
  • Intramuscular (local)
  • 20 mcg/kg twice daily
  • Collagen fiber density
  • Significantly higher Type I collagen deposition
  • Local IM delivery may optimize bioavailability at injury site; dose 2× higher than IP studies
  • Rat Rotator Cuff Tear (2020)
  • Subcutaneous
  • 15 mcg/kg daily
  • VEGF expression and capillary count
  • 3.2× higher capillary density at day 7
  • Subcutaneous route replicates practical human use; vascular growth effect clearly demonstrated
  • Rabbit Flexor Tendon Repair (2019)
  • Intra-tendon injection
  • 50 mcg total dose
  • Adhesion formation and gliding function
  • Reduced adhesions without strength compromise
  • Intra-tendon route not practical for most human tendons; adhesion reduction clinically meaningful
More references

Related material